Neuroactive Steroid Formulations And Methods Of Treating Cns Disorders

Patent No. EP2806877 (titled "Neuroactive Steroid Formulations And Methods Of Treating Cns Disorders") was filed by Sage Therapeutics on Jan 23, 2013. The application was issued on Jan 29, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR SCHONJul 8, 2020-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2806877

SAGE THERAPEUTICS
Application Number
EP13740743A
Filing Date
Jan 23, 2013
Status
Patent Maintained As Amended
Dec 26, 2024
Publication Date
Jan 29, 2025